
Evofem Biosciences, Inc.
Evofem Biosciences, Inc. (EVFM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVFM · as of Jun 9, 2026
Key Statistics
Explore Evofem Biosciences, Inc. Data
evfm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The EVFM analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $66.25, representing +883233.33% upside from the current price of $0.01.
Competitors & Peers
evfm competitorsStock Performance
Full HistoryAbout Evofem Biosciences, Inc.
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive…
what is evofem biosciences, inc. · evfm stock overview · evofem biosciences, inc. company profile · who is evofem biosciences, inc. ceo · evfm OTC · evofem biosciences, inc. headquarters · evofem biosciences, inc. business segments
About Stock Overview & Key Data
Evofem Biosciences, Inc. (EVFM) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 20, 2014. As of the latest trading session, EVFM stock price is $0.01, with a market capitalization of $993,975. The stock has returned -25.00% over the past 12 months and -21.05% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Evofem Biosciences, Inc. stock is Buy, with an average 12-month price target of $66.25. In fiscal year 2025, Evofem Biosciences, Inc. reported revenue of $20.2M and net income of $391000.00. For detailed data — including Evofem Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evofem Biosciences, Inc. (EVFM) stock price is $0.01. The stock is traded on OTC under the ticker symbol EVFM. The 52-week range is $0.00 – $0.02.